首页> 外文期刊>New Zealand Laboratory News >Novozymes Biopharma wins Technology Innovation award for ground-breaking half-life extension platform
【24h】

Novozymes Biopharma wins Technology Innovation award for ground-breaking half-life extension platform

机译:诺维信生物制药凭借突破性的半衰期延长平台赢得了技术创新奖

获取原文
获取原文并翻译 | 示例
           

摘要

The award recognises the most exciting delivery technology of the year. The albumin based technology platform offers the potential to enhance patient quality of life through tailoring drug circulatory half-life to meet specific medical needs.The DDP awards acknowledge success within the drug delivery industry and were selected by peers from the pharmaceutical industry at the 16th annual DDP conference, held in Las Vegas, Nevada, in January this year.
机译:该奖项表彰了年度最激动人心的交付技术。基于白蛋白的技术平台可通过调整药物循环半衰期来满足特定的医疗需求,从而提高患者的生活质量。DDP奖项表彰了药物输送行业的成功,并由制药行业的同行评选为第16届年度DDP会议于今年1月在内华达州拉斯维加斯举行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号